Felip, E.; Gutiérrez-Chamorro, L.; Gómez, M.; Garcia-Vidal, E.; Romeo, M.; Morán, T.; Layos, L.; Pérez-Roca, L.; Riveira-Muñoz, E.; Clotet, B.;
et al. Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types. Cancers 2022, 14, 641.
https://doi.org/10.3390/cancers14030641
AMA Style
Felip E, Gutiérrez-Chamorro L, Gómez M, Garcia-Vidal E, Romeo M, Morán T, Layos L, Pérez-Roca L, Riveira-Muñoz E, Clotet B,
et al. Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types. Cancers. 2022; 14(3):641.
https://doi.org/10.3390/cancers14030641
Chicago/Turabian Style
Felip, Eudald, LucÃa Gutiérrez-Chamorro, Maica Gómez, Edurne Garcia-Vidal, Margarita Romeo, Teresa Morán, Laura Layos, Laia Pérez-Roca, Eva Riveira-Muñoz, Bonaventura Clotet,
and et al. 2022. "Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types" Cancers 14, no. 3: 641.
https://doi.org/10.3390/cancers14030641
APA Style
Felip, E., Gutiérrez-Chamorro, L., Gómez, M., Garcia-Vidal, E., Romeo, M., Morán, T., Layos, L., Pérez-Roca, L., Riveira-Muñoz, E., Clotet, B., Fernandez, P. L., MesÃa, R., MartÃnez-Cardús, A., Ballana, E., & MargelÃ, M.
(2022). Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types. Cancers, 14(3), 641.
https://doi.org/10.3390/cancers14030641